tirzepatide brain GLP-1 medications may only temporarily suppress activity involved in 'food noise' Frontiers | The lack of

It rises early when liver cells become inflamed

Patients should be aware of early signs of trouble

Between 2017 and 2022, GLP-1 medication use among people with diabetes increased by 230%, rising from approximately 1.5 million to 5.1 million adults

Apple Inc.: Facts and Statistics (2024)

A very gradual schedule allows the person and their treatment team to monitor the psychological response to reduced appetite alongside the physical effects

In addition, office-based measurements of systolic and diastolic blood pressure (BP) were reduced with tirzepatide, but heart rate (HR) was increased, consistent with known effects of GLP-1 agonists